Tag: Genomics | Page 62 | NAI 500 | Page 62

- English
  - 简体中文
  - 繁體中文

Home
Genomics

Filter

Roche Snags Chinese Approval for Lung Cancer Drug Alecensa

Aug 21, 2018

Ascentage Pharma Officially Announces its Hong Kong IPO

Aug 21, 2018

Alphabet-backed One Medical is in talks to raise more than $200 million

Aug 20, 2018

Harbour BioMed Inks Partnership Deal with Sichuan Kelun-Biotech Worth $350 Million-Plus

Aug 20, 2018

China Biologic Management Makes $3.9 Billion Take-Private Offer

Aug 20, 2018

Ping An Good Doctor To Set Up Joint Venture With Grab In Southeast Asia

Aug 17, 2018

Novo Nordisk Acquires Ziylo in Possible $800 Million-Plus Deal,

Novo Nordisk Acquires Ziylo in Possible $800 Million-Plus Deal

Aug 17, 2018

中国杭州阿诺医药开设波士顿创新中心

Adlai Nortye of Hangzhou Opens Boston Innovation Center

Aug 17, 2018

Fosun International Invests $5M In Israeli Fintech Start-up The Floor

Aug 16, 2018

Shanghai ChemPartner Announces Merger Deal Closure with Quantum

Aug 16, 2018

Sirnaomics to Start US Trial of siRNA Treatment for Bile Duct Cancer

Aug 16, 2018

YiChang HEC Pharm Raises $400 Million from Blackstone Group

Aug 16, 2018

Buck Institute, Insilico and Juvenescence Form Napa to Develop Anti-Aging Drug

Aug 15, 2018

Loncar Launches China BioPharma ETF on NASDAQ Exchange

Aug 15, 2018

CrownBio Acquires Rights to Drug Development Models from Shanghai Model Organisms

Aug 15, 2018

Magnolia Neurosciences Launches with $31 Million

Aug 14, 2018

CANbridge Approved for China Phase Ib/III Trial of Esophageal Cancer Drug

Aug 14, 2018

Sihuan Pharma Starts China Phase II Lung Cancer Trial

Aug 14, 2018